Immuneering Corporation (IMRX) Capital expenditures 2020–2025
Immuneering Corporation (IMRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$142,226FY2025 · since FY2020: $53,415 → $142,226
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $142,226 | +67.6% |
| FY2024 | $84,875 | -75.2% |
| FY2023 | $342,746 | -53.8% |
| FY2022 | $742,483 | +1121.5% |
| FY2021 | $60,786 | +13.8% |
| FY2020 | $53,415 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice